Vik Chopra
Stock Analyst at Wells Fargo
(1.79)
# 3,279
Out of 5,030 analysts
51
Total ratings
36.36%
Success rate
-5.87%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATEC Alphatec Holdings | Maintains: Overweight | $14 → $16 | $14.89 | +7.45% | 2 | Oct 16, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $79 → $82 | $72.16 | +13.64% | 5 | Sep 15, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $17 → $15 | $10.41 | +44.09% | 3 | Aug 13, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $76 → $66 | $59.58 | +10.78% | 10 | Aug 8, 2025 | |
| ENOV Enovis | Maintains: Overweight | $48 → $41 | $31.42 | +30.49% | 4 | Aug 8, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $16 → $15 | $12.51 | +19.90% | 3 | Aug 8, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $17 → $19 | $19.96 | -4.81% | 3 | Aug 1, 2025 | |
| ALGN Align Technology | Maintains: Overweight | $246 → $199 | $130.45 | +52.55% | 3 | Jul 31, 2025 | |
| MASI Masimo | Maintains: Overweight | $205 → $190 | $146.78 | +29.45% | 9 | May 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $25 → $13 | $15.08 | -13.79% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $75 | $62.98 | +19.09% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $57 | $45.19 | +26.13% | 5 | May 1, 2025 |
Alphatec Holdings
Oct 16, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $14.89
Upside: +7.45%
Solventum
Sep 15, 2025
Maintains: Equal-Weight
Price Target: $79 → $82
Current: $72.16
Upside: +13.64%
NeuroPace
Aug 13, 2025
Maintains: Overweight
Price Target: $17 → $15
Current: $10.41
Upside: +44.09%
Globus Medical
Aug 8, 2025
Maintains: Overweight
Price Target: $76 → $66
Current: $59.58
Upside: +10.78%
Enovis
Aug 8, 2025
Maintains: Overweight
Price Target: $48 → $41
Current: $31.42
Upside: +30.49%
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $16 → $15
Current: $12.51
Upside: +19.90%
Envista Holdings
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $17 → $19
Current: $19.96
Upside: -4.81%
Align Technology
Jul 31, 2025
Maintains: Overweight
Price Target: $246 → $199
Current: $130.45
Upside: +52.55%
Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205 → $190
Current: $146.78
Upside: +29.45%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25 → $13
Current: $15.08
Upside: -13.79%
May 6, 2025
Maintains: Equal-Weight
Price Target: $80 → $75
Current: $62.98
Upside: +19.09%
May 1, 2025
Maintains: Equal-Weight
Price Target: $70 → $57
Current: $45.19
Upside: +26.13%